{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:34:42Z","timestamp":1767598482949,"version":"3.41.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010327","name":"Cincinnati Children\u2019s Research Foundation","doi-asserted-by":"publisher","award":["GAP Award"],"award-info":[{"award-number":["GAP Award"]}],"id":[{"id":"10.13039\/100010327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-025-01126-y","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:00:45Z","timestamp":1752609645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"23","author":[{"given":"Kim","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ndate","family":"Fall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei A.","family":"Grom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermine I.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Towe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant S.","family":"Schulert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"1126_CR1","unstructured":"Fautrel B, Mitrovic S, De Matteis A, Bindoli S, Ant\u00f3n J, Belot A et al. EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease. Ann Rheum Dis. 2024 [cited 2025 May 26];83. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39317417\/"},{"key":"1126_CR2","doi-asserted-by":"crossref","unstructured":"Lee JJY, Schneider R. Systemic Juvenile Idiopathic Arthritis. Pediatr Clin North Am. 2018 [cited 2021 Jan 31];65:691\u2013709. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30031494","DOI":"10.1016\/j.pcl.2018.04.005"},{"key":"1126_CR3","doi-asserted-by":"crossref","unstructured":"Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016 [cited 2016 Oct 27];12:259\u201368. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27009539","DOI":"10.1038\/nrrheum.2015.179"},{"key":"1126_CR4","doi-asserted-by":"publisher","unstructured":"Schulert GS, Yasin S, Carey B, Chalk C, Do T, Schapiro AH et al. Systemic Juvenile Idiopathic Arthritis-Lung Disease: Characterization and Risk Factors. Arthritis & Rheumatology. 2019 [cited 2019 Aug 19];art.41073. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/art.41073","DOI":"10.1002\/art.41073"},{"key":"1126_CR5","doi-asserted-by":"crossref","unstructured":"Kimura Y, Weiss JE, Haroldson KL, Lee T, Punaro M, Oliveira S et al. Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 [cited 2015 Sep 1];65:745\u201352. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4476507%26;tool=pmcentrez%26;rendertype=abstract","DOI":"10.1002\/acr.21889"},{"key":"1126_CR6","unstructured":"Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K et al. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019 [cited 2019 Nov 18];78:1722\u201331. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31562126"},{"key":"1126_CR7","doi-asserted-by":"crossref","unstructured":"Zhan W, Yang J, Qiu L, Yang K, Ye X, Shangguan Y et al. Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study. Pediatr Rheumatol Online J. 2024 [cited 2025 Feb 9];22:96. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39449050\/","DOI":"10.1186\/s12969-024-01028-5"},{"key":"1126_CR8","doi-asserted-by":"crossref","unstructured":"Wobma H, Bachrach R, Farrell J, Chang MH, Day-Lewis M, Dedeoglu F et al. Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis. ACR Open Rheumatol. 2023 [cited 2024 Oct 23];5:556\u201362. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37688362\/","DOI":"10.1002\/acr2.11600"},{"key":"1126_CR9","doi-asserted-by":"crossref","unstructured":"Towe C, Grom AA, Schulert GS. Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease. Paediatr Drugs. 2023 [cited 2024 Oct 23];25:649\u201358. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37787872\/","DOI":"10.1007\/s40272-023-00593-8"},{"key":"1126_CR10","doi-asserted-by":"crossref","unstructured":"Canna SW, Schulert GS, de Jesus A, Pickering A, Brunner H, Gadina M et al. Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3\u20134, 2019. Pediatr Rheumatol Online J. 2020 [cited 2020 Aug 17];18:53. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32664935","DOI":"10.1186\/s12969-020-00444-7"},{"key":"1126_CR11","doi-asserted-by":"crossref","unstructured":"Saidi O, Rochette E, Bourdier P, Ratel S, Merlin E, Pereira B et al. Sleep in children and adolescents with juvenile idiopathic arthritis: a systematic review and meta-analysis of case-control studies. Sleep. 2022;45.","DOI":"10.1093\/sleep\/zsab233"},{"key":"1126_CR12","doi-asserted-by":"crossref","unstructured":"Stinson JN, Hayden JA, Ahola Kohut S, Soobiah C, Cartwright J, Weiss SK et al. Sleep problems and associated factors in children with juvenile idiopathic arthritis: a systematic review. Pediatr Rheumatol Online J. 2014 [cited 2024 Oct 24];12. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24940168\/","DOI":"10.1186\/1546-0096-12-19"},{"key":"1126_CR13","doi-asserted-by":"crossref","unstructured":"Huang Y, Sompii-Montgomery L, Patti J, Pickering A, Yasin S, Do T et al. Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. Arthritis Care Res (Hoboken). 2024 [cited 2024 Oct 24];76:328\u201339. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37691306\/","DOI":"10.1002\/acr.25234"},{"key":"1126_CR14","unstructured":"The promise of PROMIS. using item response theory to improve assessment of patient-reported outcomes - PubMed. [cited 2024 Oct 24]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16273785\/"},{"key":"1126_CR15","doi-asserted-by":"crossref","unstructured":"Niemitz M, Schwerk N, Goldbeck L, Griese M. Development and validation of a health-related quality of life questionnaire for pediatric patients with interstitial lung disease. Pediatr Pulmonol. 2018 [cited 2022 Jun 7];53:954\u201363. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29687642","DOI":"10.1002\/ppul.24018"},{"key":"1126_CR16","doi-asserted-by":"crossref","unstructured":"Butbul Aviel Y, Stremler R, Benseler SM, Cameron B, Laxer RM, Ota S et al. Sleep and fatigue and the relationship to pain, disease activity and quality of life in juvenile idiopathic arthritis and juvenile dermatomyositis. Rheumatology (Oxford). 2011 [cited 2022 Nov 27];50:2051\u201360. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21873265","DOI":"10.1093\/rheumatology\/ker256"},{"key":"1126_CR17","doi-asserted-by":"crossref","unstructured":"Arnstad ED, Glerup M, Rypdal V, Peltoniemi S, Fasth A, Nielsen S et al. Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort. Pediatr Rheumatol Online J. 2021 [cited 2024 Oct 23];19. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33736650\/","DOI":"10.1186\/s12969-021-00499-0"},{"key":"1126_CR18","doi-asserted-by":"crossref","unstructured":"Swanson C, Khan EK, Cooper A, Ibarra M, Tam-Williams J. Pediatric systemic juvenile idiopathic arthritis-related lung disease: Description of clinical cohort and review of management. Pediatr Pulmonol. 2024 [cited 2024 Oct 23];59:724\u201333. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38155594\/","DOI":"10.1002\/ppul.26821"},{"key":"1126_CR19","unstructured":"Steroid-Induced Sleep Disturbance and Delirium. A Focused Review for Critically Ill Patients - PubMed. [cited 2025 Feb 9]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32669778\/"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01126-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-025-01126-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01126-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:00:49Z","timestamp":1752609649000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-025-01126-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1186\/s12969-025-01126-y","relation":{},"ISSN":["1546-0096"],"issn-type":[{"type":"electronic","value":"1546-0096"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Cincinnati Children\u2019s Hospital Medical Center Institutional Review Board (2019\u2009\u2212\u20090888) with a waiver of consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Dr. Schulert has received consulting fees from Novartis and Boehringer Ingelheim and research support from IpiNovyx. Dr. Grom has received consulting fees from Novartis and SOBI. All author authors report no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}